Chào mừng trở lại
Tham gia Cointime
Đăng nhập với email
Đăng nhập với
Đăng ký
Renovar
About
Renovar is engaged in the development of diagnostic tests for the treatment of kidney diseases.
- 1 - 10
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $1.20M
- Industries
- Biotechnology
- Founded date
- Jan 1, 1999
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Renovar engages in the discovery and development of diagnostic tests based on a portfolio of protein biomarkers for kidney disease and transplant monitoring. It provides a portfolio of protein biomarkers that indicate kidney injury using its urinary immunoassay platform; and CFSE Flow Kit that is used for tracking eight generations of cell proliferation in-vivo and in-vitro for mouse and human cells by flow cytometry. The company also offers custom assays and study services to support research activities, including biomarker selection and assay panel development, study design, data analysis, and samples testing. Renovar, Inc. was founded in 1999 and is headquartered in Appleton, Wisconsin.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 30, 2006 | Series B | $1.20M | 1 |
NEW Capital Fund
|
— | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
NEW Capital Fund
|
Yes | Series B |
